BERLIN, July 13 /PRNewswire/ -- The new "German Alliance for Industrial Biotechnology" is making its first appearance. An initiative recently launched by Germany Trade & Invest, the network includes both research institutions and producers, namely industrial biotechnology clusters and chemical parks, in addition to regional investment agencies. The alliance aims to bolster Germany's biotechnology sector by creating new business opportunities across the entire value chain. Members of the alliance will be presenting together at the Sixth Annual World Congress on Industrial Biotechnology and Bioprocessing from July 19-22 in Montreal, Canada.
Germany's biotechnology industry is the largest in Europe, posting annual revenues of over EUR 2 billion. There are nearly 600 biotechnology companies located in Germany. Within this industry, the industrial biotechnology sector has shown rapid growth in recent years. From 2005 to 2007, the industry doubled its revenue to EUR 50.4 million.
The "German Alliance for Industrial Biotechnology" brings together a number of partners. The network is made up of chemical parks, biotechnology start-ups, and scientific institutes from across Germany. Together, they initiate research and development projects that strengthen both academic and market competitiveness. A number of economic development agencies also contribute to the network, offering business services for investors and local expertise.
Rolf O. Gohdes, Director of Chemicals and Healthcare at Germany Trade &
Invest, stated: "We believe the German Alliance for Industrial Biotechnology
represents an exceptional chance for biotechnology companies to grow and
prosper. Germany offers a number of unique business advantages. Our
highly-skilled researchers and cutting-edge innovation combine to make
Germany one of the most attractive locations for biotechnology in the world.
Especially interesting are the ch
|SOURCE Germany Trade and Invest|
Copyright©2009 PR Newswire.
All rights reserved